AGIO
Price:
$34.16
Market Cap:
$2.03B
Agios Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to the research and advancement of new treatments, specifically targeting cellular metabolism and related biological fields. The company's offerings include PYRUKYND (mitapivat), a medication designed to activate both wild-type and various mutated pyruvate kinase (PK) enzymes, used in the management of hemolytic anemias. Additionally, Agios is developing AG-946, which is currently undergoing Phase I clinical studies for treating hemolytic anemias and other diseases. Established in 2007, the company's main office is located in Cambridge, Massachusetts.
Industry
Biotechnology
IPO Date
2013-07-24
Stock Exchange
NASDAQ
Ticker
AGIO
According to Agios Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -4.71. This represents a change of 1.13% compared to the average of -4.66 of the last 4 quarters.
The mean historical PE Ratio of Agios Pharmaceuticals, Inc. over the last ten years is -5.71. The current -4.71 PE Ratio has changed 8.15% with respect to the historical average. Over the past ten years (40 quarters), AGIO's PE Ratio was at its highest in in the December 2022 quarter at 2.24. The PE Ratio was at its lowest in in the June 2018 quarter at -17.70.
Average
-5.71
Median
-6.93
Minimum
-9.14
Maximum
2.77
Discovering the peaks and valleys of Agios Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 28.44%
Maximum Annual PE Ratio = 2.77
Minimum Annual Increase = -237.98%
Minimum Annual PE Ratio = -9.14
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -3.82 | -237.98% |
| 2024 | 2.77 | -178.75% |
| 2023 | -3.52 | -47.00% |
| 2022 | -6.64 | 28.44% |
| 2021 | -5.17 | -43.46% |
| 2020 | -9.14 | 26.54% |
| 2019 | -7.22 | -5.53% |
| 2018 | -7.65 | -9.72% |
| 2017 | -8.47 | 2.90% |
| 2016 | -8.23 | -60.06% |
The current PE Ratio of Agios Pharmaceuticals, Inc. (AGIO) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.52
5-year avg
-3.28
10-year avg
-5.71
Agios Pharmaceuticals, Inc.’s PE Ratio is greater than Denali Therapeutics Inc. (-8.09), less than Recursion Pharmaceuticals, Inc. (-2.69), greater than Beam Therapeutics Inc. (-53.34), greater than Arcus Biosciences, Inc. (-7.68), greater than 89bio, Inc. (-7.78), greater than Cogent Biosciences, Inc. (-11.21), greater than ImmunityBio, Inc. (-8.62), less than Galapagos N.V. (3.32), less than Sarepta Therapeutics, Inc. (28.27), less than Liquidia Corporation (297.24),
| Company | PE Ratio | Market cap |
|---|---|---|
| -8.09 | $3.70B | |
| -2.69 | $1.44B | |
| -53.34 | $3.51B | |
| -7.68 | $2.45B | |
| -7.78 | $2.20B | |
| -11.21 | $5.90B | |
| -8.62 | $7.71B | |
| 3.32 | $1.84B | |
| 28.27 | $1.85B | |
| 297.24 | $6.32B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Agios Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Agios Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Agios Pharmaceuticals, Inc.'s PE Ratio?
How is the PE Ratio calculated for Agios Pharmaceuticals, Inc. (AGIO)?
What is the highest PE Ratio for Agios Pharmaceuticals, Inc. (AGIO)?
What is the 3-year average PE Ratio for Agios Pharmaceuticals, Inc. (AGIO)?
What is the 5-year average PE Ratio for Agios Pharmaceuticals, Inc. (AGIO)?
How does the current PE Ratio for Agios Pharmaceuticals, Inc. (AGIO) compare to its historical average?